Download PDF
J Pediatr Genet
DOI: 10.1055/s-0043-1775558
Original Article

rs1800890 Polymorphism of IL-10 and Susceptibility to Idiopathic Thrombocytopenic Purpura

Fatemeh Zeylabi
1   Thalassemia & Hemoglobinopathy Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
2   Department of Laboratory Sciences, School of Allied Medical Sciences, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
,
Mohammad Taha Jalali
3   Department of Laboratory Sciences, Hyperlipidemia Research Center, School of Allied Medical Sciences, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
,
Gholam-Abbas Kaydani
2   Department of Laboratory Sciences, School of Allied Medical Sciences, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
,
Kaveh Jaseb
1   Thalassemia & Hemoglobinopathy Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
,
Najmaldin Saki 
1   Thalassemia & Hemoglobinopathy Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
2   Department of Laboratory Sciences, School of Allied Medical Sciences, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
› Author Affiliations Funding This research was financially supported by a grant (No. Th-0006) from the vice chancellor for research affairs of Ahvaz Jundishapur University of Medical Sciences. This article is issued from the thesis of Fatemeh Zeylabi, MSc student of hematology and blood banking.
› Further Information
    Permissions and Reprints

Abstract

Immune thrombocytopenic purpura (ITP) is an immune bleeding disorder that is reported in approximately 2 out of every 100,000 adults with a mean age of 50 years. Several factors such as various genetic backgrounds are associated with the pathogenesis of ITP. Interleukin (IL)-10 is a complicated cytokine that has a role in tumor progression, antitumor immunity, and immune system regulation. rs1800890 is an IL-10 single nucleotide polymorphism linked to lower levels of IL-10. A total of 67 patients with ITP and 70 healthy individuals (controls) were considered in this study. The IL-10 polymorphism was detected by the amplification refractory mutation system–polymerase chain reaction technique. According to our analysis, individual carriers of the AA genotype were less likely to develop ITP. The AT genotype was more common in patients with ITP in comparison to the control group. However, there was no significant association between rs1800890 genotypes (p = 0.775, odds ratio =1.517, 95%) in the acute and chronic groups. We observed that women had a higher mean frequency of this polymorphism (p = 0.0012). The rs1800890 AA genotype was associated with the highest platelet counts. However, the mean platelet volume and platelet distribution width values among alleles of the polymorphisms did not vary significantly. The IL-10 rs1800890 polymorphism may have a role in idiopathic thrombocytopenic purpura etiology. As a result, more research with a larger number of sample sizes is suggested.

Keywords

genotype - immune thrombocytopenic purpura - megakaryocyte - IL-10 - platelet - polymorphism


Publication History

Received: 04 July 2022

Accepted: 26 July 2023

Article published online:
29 September 2023

© 2023. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Terrell DR, Beebe LA, Vesely SK, Neas BR, Segal JB, George JN. The incidence of immune thrombocytopenic purpura in children and adults: a critical review of published reports. Am J Hematol 2010; 85 (03) 174-180
    CrossrefPubMedGoogle Scholar
  • 2 Onisâi M, Vlădăreanu A-M, Spînu A, Găman M, Bumbea H. Idiopathic thrombocytopenic purpura (ITP) - new era for an old disease. Rom J Intern Med 2019; 57 (04) 273-283
    PubMedGoogle Scholar
  • 3 Ramírez-López A, Álvarez Román MT, Monzón Manzano E. et al. The importance of platelet glycoside residues in the haemostasis of patients with immune thrombocytopaenia. J Clin Med 2021; 10 (08) 1661
    CrossrefPubMedGoogle Scholar
  • 4 Neylon AJ, Saunders PW, Howard MR, Proctor SJ, Taylor PR. Northern Region Haematology Group. Clinically significant newly presenting autoimmune thrombocytopenic purpura in adults: a prospective study of a population-based cohort of 245 patients. Br J Haematol 2003; 122 (06) 966-974
    CrossrefPubMedGoogle Scholar
  • 5 Perera M, Garrido T. Advances in the pathophysiology of primary immune thrombocytopenia. Hematology 2017; 22 (01) 41-53
    CrossrefPubMedGoogle Scholar
  • 6 Provan D, Newland AC. Current management of primary immune thrombocytopenia. Adv Ther 2015; 32 (10) 875-887
    CrossrefPubMedGoogle Scholar
  • 7 Rodeghiero F. Is ITP a thrombophilic disorder?. Am J Hematol 2016; 91 (01) 39-45
    CrossrefPubMedGoogle Scholar
  • 8 Akbayram S, Dogan M, Ustyol L. et al. The clinical outcome of 260 pediatric ITP patients in one center. Clin Appl Thromb Hemost 2011; 17 (06) E30-E35
    CrossrefPubMedGoogle Scholar
  • 9 Zainal A, Salama A, Alweis R. Immune thrombocytopenic purpura. J Community Hosp Intern Med Perspect 2019; 9 (01) 59-61
    CrossrefPubMedGoogle Scholar
  • 10 Cortelazzo S, Finazzi G, Buelli M, Molteni A, Viero P, Barbui T. High risk of severe bleeding in aged patients with chronic idiopathic thrombocytopenic purpura. Blood 1991; 77 (01) 31-33
    CrossrefPubMedGoogle Scholar
  • 11 Aledort LM, Hayward CP, Chen MG, Nichol JL, Bussel J. ITP Study Group. Prospective screening of 205 patients with ITP, including diagnosis, serological markers, and the relationship between platelet counts, endogenous thrombopoietin, and circulating antithrombopoietin antibodies. Am J Hematol 2004; 76 (03) 205-213
    CrossrefPubMedGoogle Scholar
  • 12 Yusufjanovich EU, Irisbaevich MG, Rafiqovich ZA. et al. IDIOPATHIC THROMBOCYTOPENIC PURPURA IN PREGNANCY. In: E Conference Zone; 2023: 13-20
    PubMedGoogle Scholar
  • 13 Chandrakala S, Toshniwal M, Halvawala M. et al. Efficacy and safety of biosimilar romiplostim versus innovator romiplostim in patients with chronic immune thrombocytopenia. Indian J Hematol Blood Transfus 2023; 66 (01) 96-100
    PubMedGoogle Scholar
  • 14 Zufferey A, Kapur R, Semple JW. Pathogenesis and therapeutic mechanisms in immune thrombocytopenia (ITP). J Clin Med 2017; 6 (02) 16
    CrossrefPubMedGoogle Scholar
  • 15 Kim TO, Flanagan JM, Habibi A. et al. Genetic variants in toll-like receptor 4 are associated with lack of steroid-responsiveness in pediatric ITP patients. Am J Hematol 2020; 95 (04) 395-400
    CrossrefPubMedGoogle Scholar
  • 16 Cines DB, Blanchette VS. Immune thrombocytopenic purpura. N Engl J Med 2002; 346 (13) 995-1008
    CrossrefPubMedGoogle Scholar
  • 17 Olsson B, Andersson P-O, Jernås M. et al. T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura. Nat Med 2003; 9 (09) 1123-1124
    CrossrefPubMedGoogle Scholar
  • 18 Semple JW, Freedman J. Increased antiplatelet T helper lymphocyte reactivity in patients with autoimmune thrombocytopenia. Blood 1991; 78 (10) 2619-2625
    CrossrefPubMedGoogle Scholar
  • 19 Cines DB, Cuker A, Semple JW. Pathogenesis of immune thrombocytopenia. Presse Med 2014; 43 (4 Pt 2): e49-e59
    CrossrefPubMedGoogle Scholar
  • 20 Zhang H-Y, Hou M, Zhang X-H, Guan XH, Sun GZ. [The diagnostic value of platelet glycoprotein-specific autoantibody detection in idiopathic thrombocytopenic purpura]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2004; 12 (02) 204-206
    PubMedGoogle Scholar
  • 21 Khodadi E, Asnafi AA, Shahrabi S, Shahjahani M, Saki N. Bone marrow niche in immune thrombocytopenia: a focus on megakaryopoiesis. Ann Hematol 2016; 95 (11) 1765-1776
    CrossrefPubMedGoogle Scholar
  • 22 Wang N, Li GN, Wang XB, Liang T, Hu L. TNF-α promoter single nucleotide polymorphisms and haplotypes associate with susceptibility of immune thrombocytopenia in Chinese adults. Hum Immunol 2014; 75 (09) 980-985
    CrossrefPubMedGoogle Scholar
  • 23 Johnsen J. Pathogenesis in immune thrombocytopenia: new insights. Hematology (Am Soc Hematol Educ Program) 2012; 2012: 306-312
    CrossrefPubMedGoogle Scholar
  • 24 Hashimoto SI, Komuro I, Yamada M, Akagawa KS. IL-10 inhibits granulocyte-macrophage colony-stimulating factor-dependent human monocyte survival at the early stage of the culture and inhibits the generation of macrophages. J Immunol 2001; 167 (07) 3619-3625
    CrossrefPubMedGoogle Scholar
  • 25 de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991; 174 (05) 1209-1220
    CrossrefPubMedGoogle Scholar
  • 26 Li X, Lu P, Li B. et al. Interleukin 2 and interleukin 10 function synergistically to promote CD8+ T cell cytotoxicity, which is suppressed by regulatory T cells in breast cancer. Int J Biochem Cell Biol 2017; 87: 1-7
    CrossrefPubMedGoogle Scholar
  • 27 Fillatreau S, Sweenie CH, McGeachy MJ, Gray D, Anderton SM. B cells regulate autoimmunity by provision of IL-10. Nat Immunol 2002; 3 (10) 944-950
    CrossrefPubMedGoogle Scholar
  • 28 Macatonia SE, Doherty TM, Knight SC, O'Garra A. Differential effect of IL-10 on dendritic cell-induced T cell proliferation and IFN-gamma production. J Immunol 1993; 150 (09) 3755-3765
    CrossrefPubMedGoogle Scholar
  • 29 Asadullah K, Sterry W, Stephanek K. et al. IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: a new therapeutic approach. J Clin Invest 1998; 101 (04) 783-794
    CrossrefPubMedGoogle Scholar
  • 30 DeBruyne LA, Li K, Chan SY, Qin L, Bishop DK, Bromberg JS. Lipid-mediated gene transfer of viral IL-10 prolongs vascularized cardiac allograft survival by inhibiting donor-specific cellular and humoral immune responses. Gene Ther 1998; 5 (08) 1079-1087
    CrossrefPubMedGoogle Scholar
  • 31 Katsikis PD, Chu C-Q, Brennan FM, Maini RN, Feldmann M. Immunoregulatory role of interleukin 10 in rheumatoid arthritis. J Exp Med 1994; 179 (05) 1517-1527
    CrossrefPubMedGoogle Scholar
  • 32 Topbaş N. Ataksi telenjiektazili hastaların klinik ve laboratuvar özellikleri. 2022
    PubMedGoogle Scholar
  • 33 Swiątek BJ. Is interleukin-10 gene polymorphism a predictive marker in HCV infection?. Cytokine Growth Factor Rev 2012; 23 (1-2): 47-59
    CrossrefPubMedGoogle Scholar
  • 34 Audia S, Mahévas M, Samson M, Godeau B, Bonnotte B. Pathogenesis of immune thrombocytopenia. Autoimmun Rev 2017; 16 (06) 620-632
    CrossrefPubMedGoogle Scholar
  • 35 Hong P, Feng W-Y, Fu L-H, Jin J, Fu JP. Associations between genetic polymorphisms in interleukin-10 and hematological oncology: evidence from a meta-analysis. Cancer Biol Ther 2020; 21 (04) 372-378
    CrossrefPubMedGoogle Scholar
  • 36 Lv T-T, Wu J, Li J. et al. Association of interleukin-10 gene single nucleotide polymorphisms with susceptibility to systemic lupus erythematosus in a Chinese population. Gene 2018; 642: 549-554
    CrossrefPubMedGoogle Scholar
  • 37 Zhang T-P, Lv T-T, Xu S-Z, Pan HF, Ye DQ. Association of interleukin-10 gene single nucleotide polymorphisms with rheumatoid arthritis in a Chinese population. Postgrad Med J 2018; 94 (1111): 284-288
    CrossrefPubMedGoogle Scholar
  • 38 Mokhtar GM, El-Beblawy NM, Adly AA, Elbarbary NS, Kamal TM, Hasan EM. Cytokine gene polymorphism [tumor necrosis factor-alpha (-308), IL-10 (-1082), IL-6 (-174), IL-17F, 1RaVNTR] in pediatric patients with primary immune thrombocytopenia and response to different treatment modalities. Blood Coagul Fibrinolysis 2016; 27 (03) 313-323
    CrossrefPubMedGoogle Scholar
  • 39 Makhlouf MM, Abd Elhamid SM. Expression of IL4 (VNTR intron 3) and IL10 (-627) genes polymorphisms in childhood immune thrombocytopenic purpura. Lab Med 2014; 45 (03) 211-219
    CrossrefPubMedGoogle Scholar
  • 40 Tesse R, Del Vecchio GC, De Mattia D, Sangerardi M, Valente F, Giordano P. Association of interleukin-(IL)10 haplotypes and serum IL-10 levels in the progression of childhood immune thrombocytopenic purpura. Gene 2012; 505 (01) 53-56
    CrossrefPubMedGoogle Scholar
  • 41 Miltiadous O, Hou M, Bussel JB. Identifying and treating refractory ITP: difficulty in diagnosis and role of combination treatment. Blood 2020; 135 (07) 472-490
    CrossrefPubMedGoogle Scholar
  • 42 LeVine DN, Brooks MB. Immune thrombocytopenia (ITP): Pathophysiology update and diagnostic dilemmas. Vet Clin Pathol 2019; 48 (Suppl. 01) 17-28
    CrossrefPubMedGoogle Scholar
  • 43 Neunert C, Lim W, Crowther M, Cohen A, Solberg Jr L, Crowther MA. American Society of Hematology. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood 2011; 117 (16) 4190-4207
    CrossrefPubMedGoogle Scholar
  • 44 Cines DB, Bussel JB, Liebman HA, Luning Prak ET. The ITP syndrome: pathogenic and clinical diversity. Blood 2009; 113 (26) 6511-6521
    CrossrefPubMedGoogle Scholar
  • 45 Chen X, Xu J, Chen Z. et al. Interferon-γ +874A/T and interleukin-4 intron3 VNTR gene polymorphisms in Chinese patients with idiopathic thrombocytopenic purpura. Eur J Haematol 2007; 79 (03) 191-197
    CrossrefPubMedGoogle Scholar
  • 46 Li F, Ji L, Wang W. et al. Insufficient secretion of IL-10 by Tregs compromised its control on over-activated CD4+ T effector cells in newly diagnosed adult immune thrombocytopenia patients. Immunol Res 2015; 61 (03) 269-280
    CrossrefPubMedGoogle Scholar
  • 47 Pehlivan M, Okan V, Sever T. et al. Investigation of TNF-alpha, TGF-beta 1, IL-10, IL-6, IFN-gamma, MBL, GPIA, and IL1A gene polymorphisms in patients with idiopathic thrombocytopenic purpura. Platelets 2011; 22 (08) 588-595
    CrossrefPubMedGoogle Scholar
  • 48 Cho MJ, Ellebrecht CT, Payne AS. The dual nature of interleukin-10 in pemphigus vulgaris. Cytokine 2015; 73 (02) 335-341
    CrossrefPubMedGoogle Scholar
  • 49 Zhao H, Zhang Y, Xiao G, Wu N, Xu J, Fang Z. Interleukin-18 gene promoter–607 A/C polymorphism and the risk of immune thrombocytopenia. Autoimmunity 2014; 47 (07) 478-481
    CrossrefPubMedGoogle Scholar
  • 50 Zhang D, Zhang X, Ge M. et al. The polymorphisms of T cell-specific TBX21 gene may contribute to the susceptibility of chronic immune thrombocytopenia in Chinese population. Hum Immunol 2014; 75 (02) 129-133
    CrossrefPubMedGoogle Scholar
  • 51 Soliman MA, Helwa MA, Fath-Allah SK, El-Hawy MA, Badr HS, Barseem NF. IL-10 polymorphisms and T-cell subsets could affect the clinical presentation and outcome of childhood immune thrombocytopenia in Egyptian population. APMIS 2018; 126 (05) 380-388
    CrossrefPubMedGoogle Scholar
  • 52 Morgan DS, Afifi RA-R-A, El-Hoseiny SM, Amin DG, Ibrahim SYG. The potential association of tumor necrosis factor-βeta (252 G/A) cytokine gene polymorphism with immune thrombocytopenic purpura among Egyptian children. Hematology 2018; 23 (05) 299-303
    CrossrefPubMedGoogle Scholar
  • 53 Holster A, Teräsjärvi J, Vuononvirta J. et al. Polymorphisms in the promoter region of IL10 gene are associated with virus etiology of infant bronchiolitis. World J Pediatr 2018; 14 (06) 594-600
    CrossrefPubMedGoogle Scholar
  • 54 Nielsen KR, Steffensen R, Haunstrup TM. et al. Inherited variation in immune response genes in follicular lymphoma and diffuse large B-cell lymphoma. Leuk Lymphoma 2015; 56 (12) 3257-3266
    CrossrefPubMedGoogle Scholar
  • 55 El Ghannam D, Fawzy IM, Azmy E, Hakim H, Eid I. Relation of interleukin-10 promoter polymorphisms to adult chronic immune thrombocytopenic purpura in a cohort of Egyptian population. Immunol Invest 2015; 44 (07) 616-626
    CrossrefPubMedGoogle Scholar
  • 56 Dai Z-M, He A-L, Zhang W-G. et al. Association of the four common polymorphisms in interleukin-10 (rs1800890, rs1800896, rs1800871, and rs1800872) with non-Hodgkin's lymphoma risk: a meta-analysis. Int J Clin Exp Med 2014; 7 (12) 4720-4733
    PubMedGoogle Scholar
  • 57 Raedler D, Illi S, Pinto LA. et al. IL10 polymorphisms influence neonatal immune responses, atopic dermatitis, and wheeze at age 3 years. J Allergy Clin Immunol 2013; 131 (03) 789-796
    CrossrefPubMedGoogle Scholar
  • 58 Tsilidis KK, Helzlsouer KJ, Smith MW. et al. Association of common polymorphisms in IL10, and in other genes related to inflammatory response and obesity with colorectal cancer. Cancer Causes Control 2009; 20 (09) 1739-1751
    CrossrefPubMedGoogle Scholar
  • 59 Wang MH, Helzlsouer KJ, Smith MW. et al. Association of IL10 and other immune response- and obesity-related genes with prostate cancer in CLUE II. Prostate 2009; 69 (08) 874-885
    CrossrefPubMedGoogle Scholar
  • 60 Lin P-W, Huang C-M, Huang C-C. et al. The association of -627 interleukin-10 promoter polymorphism in Chinese patients with systemic lupus erythematosus. Clin Rheumatol 2007; 26 (03) 298-301
    CrossrefPubMedGoogle Scholar
  • 61 Domingues W, Kanunfre KA, Rodrigues JC, Teixeira LE, Yamamoto L, Okay TS. Preliminary report on the putative association of IL10–3575 T/A genetic polymorphism with malaria symptoms. Rev Inst Med Trop São Paulo 2016; 58: 30
    CrossrefPubMedGoogle Scholar